(Updated - September 24, 2026 6:11 AM EDT)

Guggenheim analyst Vamil Divan raised the price target on Travere Therapeutics ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst PT Change